LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1.7783
20.79 17.25 908 1001 0.9065 0.9668
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
20.79 17.25 1 1001 0.0010 -0.3849
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
20.79 17.25 1041 1001 1.0393 1.0132
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
22.76 17.25 1 1193 0.0008 -0.3725
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
22.76 17.25 909 1193 0.7616 0.9128
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
22.76 17.25 1 1193 0.0008 -0.3725
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
22.76 17.25 1065 1193 0.8923 0.9631
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
24.73 17.25 1 1290 0.0008 -0.3672
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
24.73 17.25 962 1290 0.7456 0.9079
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
24.73 17.25 1 1290 0.0008 -0.3672
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
24.73 17.25 1101 1290 0.8534 0.9497
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
26.70 17.25 1 1466 0.0007 -0.3587
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
26.70 17.25 1029 1466 0.7016 0.8924
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
26.70 17.25 1 1466 0.0007 -0.3587
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
26.70 17.25 1149 1466 0.7834 0.9253
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
28.67 17.25 1 1653 0.0006 -0.3512
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
28.67 17.25 1100 1653 0.6654 0.8800
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
28.67 17.25 1 1653 0.0006 -0.3512
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
28.67 17.25 1225 1653 0.7410 0.9110
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
30.64 17.25 1 1887 0.0005 -0.3433
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
30.64 17.25 1152 1887 0.6104 0.8594
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
30.64 17.25 1 1887 0.0005 -0.3433
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
30.64 17.25 1294 1887 0.6856 0.8916
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
32.61 17.25 1 2136 0.0005 -0.3361
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
32.61 17.25 1207 2136 0.5650 0.8423
MN20160310_N02
F13